Antibodies that react with bovine T lymphocytes expressing the T cell receptor β chain subgroup BV20 inhibit antigen recognition.

Vet Immunol Immunopathol

The Roslin Institute, Royal (Dick) School of Veterinary Studies, Easter Bush Campus, University of Edinburgh, Roslin, Midlothian, EH25 9RG, UK.

Published: April 2022

In recent years, molecular studies have provided detailed information on the bovine T cell receptor (TCR) variable gene repertoire, both in resting T cells and during T cell responses. However, studies of the biological function of the receptor have been hampered by a lack of reagents that recognise the protein. Herein, we describe the characterisation of two antibodies (IL-A47 and IL-A98) that recognise T cells expressing the TCR VB20 subfamily of BV genes. These antibodies each recognise a small subset of αβ T cells in PBMC, including subsets of both CD4 and CD8 T cells. One of the antibodies (IL-A98) recognises a smaller subset of cells within the IL-A47+ population. When tested on a panel of T cell clones expressing different αβ TCR subfamilies of β chain genes, IL-A47 was found to react only with clones expressing the BV20 subfamily, which in cattle has undergone expansion due to gene duplication; IL-A98 reacted with a subset of the BV20 subfamily members. IL-A47 was shown to profoundly inhibit recognition of target cells by cytotoxic T cell clones, an effect that was mediated via the effector T cell rather than the target cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vetimm.2022.110392DOI Listing

Publication Analysis

Top Keywords

cell receptor
8
cell clones
8
clones expressing
8
bv20 subfamily
8
target cells
8
cells
7
cell
6
antibodies
4
antibodies react
4
react bovine
4

Similar Publications

Norepinephrine in vertebrates and its invertebrate analog, octopamine, regulate the activity of neural circuits. We find that, when hungry, larvae switch activity in type II octopaminergic motor neurons (MNs) to high-frequency bursts, which coincide with locomotion-driving bursts in type I glutamatergic MNs that converge on the same muscles. Optical quantal analysis across hundreds of synapses simultaneously reveals that octopamine potentiates glutamate release by tonic type Ib MNs, but not phasic type Is MNs, and occurs via the G-coupled octopamine receptor (OAMB).

View Article and Find Full Text PDF

Learning the language of antibody hypervariability.

Proc Natl Acad Sci U S A

January 2025

Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139.

Protein language models (PLMs) have demonstrated impressive success in modeling proteins. However, general-purpose "foundational" PLMs have limited performance in modeling antibodies due to the latter's hypervariable regions, which do not conform to the evolutionary conservation principles that such models rely on. In this study, we propose a transfer learning framework called Antibody Mutagenesis-Augmented Processing (AbMAP), which fine-tunes foundational models for antibody-sequence inputs by supervising on antibody structure and binding specificity examples.

View Article and Find Full Text PDF

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas and the primary cause of mortality in patients with neurofibromatosis type 1 (NF1). These malignancies develop within preexisting benign lesions called plexiform neurofibromas (PNs). PNs are solely driven by biallelic loss eliciting RAS pathway activation, and they respond favorably to MEK inhibitor therapy.

View Article and Find Full Text PDF

Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody-drug conjugates.

Proc Natl Acad Sci U S A

January 2025

Laboratory of Precision Medicine and Biopharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

Recurrent missense mutations in the human epidermal growth factor receptor 2 (HER2) have been identified across various human cancers. Among these mutations, the active S310F mutation in the HER2 extracellular domain stands out as not only oncogenic but also confers resistance to pertuzumab, an antibody drug widely used in clinical cancer therapy, by impeding its binding. In this study, we have successfully employed computational-aided rational design to undertake directed evolution of pertuzumab, resulting in the creation of an evolved pertuzumab variant named Ptz-SA.

View Article and Find Full Text PDF

SLC35A2 modulates paramyxovirus fusion events during infection.

PLoS Pathog

January 2025

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America.

Paramyxoviruses are significant human and animal pathogens that include mumps virus (MuV), Newcastle disease virus (NDV) and the murine parainfluenza virus Sendai (SeV). Despite their importance, few host factors implicated in paramyxovirus infection are known. Using a recombinant SeV expressing destabilized eGFP (rSeVCdseGFP) in a loss-of-function CRISPR screen, we identified the CMP-sialic acid transporter (CST) gene SLC35A1 and the UDP-galactose transporter (UGT) gene SLC35A2 as essential for paramyxovirus infection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!